659 related articles for article (PubMed ID: 35065633)
1. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
2. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Xu H; Xiong C; Chen Y; Zhang C; Bai D
Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569
[TBL] [Abstract][Full Text] [Related]
3. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
Front Immunol; 2021; 12():612139. PubMed ID: 33679751
[TBL] [Abstract][Full Text] [Related]
4. Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma.
Liu T; Li ZZ; Sun L; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
BMC Cancer; 2023 Oct; 23(1):1007. PubMed ID: 37858061
[TBL] [Abstract][Full Text] [Related]
5. Identification of hepatocellular carcinoma-related genes associated with macrophage differentiation based on bioinformatics analyses.
Cao J; Zhang C; Jiang GQ; Jin SJ; Wang Q; Wang AQ; Bai DS
Bioengineered; 2021 Dec; 12(1):296-309. PubMed ID: 33380242
[TBL] [Abstract][Full Text] [Related]
6. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Prognostic Value, Immune Implication and Biological Function of
Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X
Front Immunol; 2021; 12():723293. PubMed ID: 34899687
[TBL] [Abstract][Full Text] [Related]
8. Prognostic prediction and gene regulation network of
Ji P; Wang H; Cheng Y; Liang S
J Gastrointest Oncol; 2021 Dec; 12(6):3061-3078. PubMed ID: 35070430
[TBL] [Abstract][Full Text] [Related]
9. Identifying the predictive role and the related drugs of oxidative stress genes in the hepatocellular carcinoma.
Nie G; Zhu X; Zhang H; Wang H; Yan J; Li X
Cancer Rep (Hoboken); 2024 Apr; 7(4):e1978. PubMed ID: 38599581
[TBL] [Abstract][Full Text] [Related]
10. The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy.
Zou R; Liu Y; Qiu S; Lu Y; Chen Y; Yu H; Zhu H; Zhu W; Zhu L; Feng J; Han J
Cancer Biomark; 2023; 38(4):551-566. PubMed ID: 38007640
[TBL] [Abstract][Full Text] [Related]
11. Identification of KNOP1 as a prognostic marker in hepatocellular carcinoma.
Zhang Y; Wang G; Wang M
Transl Cancer Res; 2023 Jul; 12(7):1684-1702. PubMed ID: 37588747
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma.
Jiayu F; Jiang Y; Zhou X; Zhou M; Pan J; Ke Y; Zhen J; Huang D; Jiang W
Aging (Albany NY); 2022 Dec; 14(23):9550-9578. PubMed ID: 36462500
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
Gao S; Zhang L; Wang H
Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma.
Xie H; Qin C; Zhou X; Liu J; Yang K; Nong J; Luo J; Peng T
Medicine (Baltimore); 2023 Aug; 102(33):e34765. PubMed ID: 37603520
[TBL] [Abstract][Full Text] [Related]
15. Immune system‑associated genes increase malignant progression and can be used to predict clinical outcome in patients with hepatocellular carcinoma.
Huang R; Chen Z; Li W; Fan C; Liu J
Int J Oncol; 2020 May; 56(5):1199-1211. PubMed ID: 32319580
[TBL] [Abstract][Full Text] [Related]
16. Role of miR
Cao Z; Zeng L; Wang Z; Zhou Y; Qian K
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1281-1295. PubMed ID: 38044639
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients.
Wang S; Wu X; Wu X; Cheng J; Chen Q; Qi Z
BMC Cancer; 2024 Jan; 24(1):156. PubMed ID: 38291366
[TBL] [Abstract][Full Text] [Related]
18. [Overexpression of Nei endonuclease VIII-like protein 3 in hepatocellular carcinoma indicates increased levels of immune infiltration and an unfavorable prognosis].
Wang GN; Zhang YP; Wang MC; Han W; Zhang YC
Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):986-995. PubMed ID: 37872095
[No Abstract] [Full Text] [Related]
19. Expression patterns of cluster of differentiation 147 impact the prognosis of hepatocellular carcinoma.
Xu YJ; He HJ; Wu P; Li WB
World J Gastrointest Oncol; 2023 Aug; 15(8):1412-1423. PubMed ID: 37663949
[TBL] [Abstract][Full Text] [Related]
20. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma.
Wang J; Wang Y; Xu J; Song Q; Shangguan J; Xue M; Wang H; Gan J; Gao W
Sci Prog; 2021; 104(3):368504211029429. PubMed ID: 34315286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]